185 related articles for article (PubMed ID: 21971185)
1. Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.
Ronet C; Beverley SM; Fasel N
Virulence; 2011; 2(6):547-52. PubMed ID: 21971185
[TBL] [Abstract][Full Text] [Related]
2. Leishmania RNA virus: when the host pays the toll.
Hartley MA; Ronet C; Zangger H; Beverley SM; Fasel N
Front Cell Infect Microbiol; 2012; 2():99. PubMed ID: 22919688
[TBL] [Abstract][Full Text] [Related]
3. MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden.
Ives A; Masina S; Castiglioni P; Prével F; Revaz-Breton M; Hartley MA; Launois P; Fasel N; Ronet C
PLoS One; 2014; 9(5):e96766. PubMed ID: 24801628
[TBL] [Abstract][Full Text] [Related]
4. Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.
Ives A; Ronet C; Prevel F; Ruzzante G; Fuertes-Marraco S; Schutz F; Zangger H; Revaz-Breton M; Lye LF; Hickerson SM; Beverley SM; Acha-Orbea H; Launois P; Fasel N; Masina S
Science; 2011 Feb; 331(6018):775-8. PubMed ID: 21311023
[TBL] [Abstract][Full Text] [Related]
5. Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.
Rossi M; Castiglioni P; Hartley MA; Eren RO; Prével F; Desponds C; Utzschneider DT; Zehn D; Cusi MG; Kuhlmann FM; Beverley SM; Ronet C; Fasel N
Proc Natl Acad Sci U S A; 2017 May; 114(19):4987-4992. PubMed ID: 28439019
[TBL] [Abstract][Full Text] [Related]
6. Host-pathogen interaction: Culprit within a culprit.
Olivier M
Nature; 2011 Mar; 471(7337):173-4. PubMed ID: 21390122
[No Abstract] [Full Text] [Related]
7. Leishmania Viannia guyanensis, LRV1 virus and extracellular vesicles: a dangerous trio influencing the faith of immune response during muco-cutaneous leishmaniasis.
Olivier M; Zamboni DS
Curr Opin Immunol; 2020 Oct; 66():108-113. PubMed ID: 32877837
[TBL] [Abstract][Full Text] [Related]
8. Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition.
de Carvalho RVH; Lima-Junior DS; da Silva MVG; Dilucca M; Rodrigues TS; Horta CV; Silva ALN; da Silva PF; Frantz FG; Lorenzon LB; Souza MM; Almeida F; Cantanhêde LM; Ferreira RGM; Cruz AK; Zamboni DS
Nat Commun; 2019 Nov; 10(1):5273. PubMed ID: 31754185
[TBL] [Abstract][Full Text] [Related]
9. Leishmania aethiopica field isolates bearing an endosymbiontic dsRNA virus induce pro-inflammatory cytokine response.
Zangger H; Hailu A; Desponds C; Lye LF; Akopyants NS; Dobson DE; Ronet C; Ghalib H; Beverley SM; Fasel N
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2836. PubMed ID: 24762979
[TBL] [Abstract][Full Text] [Related]
10. [Mucocutaneous leishmaniasis and an undesired passenger].
Ronet C; Beverley SM; Fasel N
Med Sci (Paris); 2011 Nov; 27(11):924-6. PubMed ID: 22130014
[No Abstract] [Full Text] [Related]
11. Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response.
Brettmann EA; Shaik JS; Zangger H; Lye LF; Kuhlmann FM; Akopyants NS; Oschwald DM; Owens KL; Hickerson SM; Ronet C; Fasel N; Beverley SM
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):11998-12005. PubMed ID: 27790981
[TBL] [Abstract][Full Text] [Related]
12. Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.
Ehrlich AK; Fernández OL; Rodriguez-Pinto D; Castilho TM; Corral Caridad MJ; Goldsmith-Pestana K; Saravia NG; McMahon-Pratt D
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28052994
[TBL] [Abstract][Full Text] [Related]
13. First Molecular Report of
Salvioni Recalde OD; Pereira Brunelli J; Rolon MS; Rojas de Arias A; Aldama O; Gómez CV
Am J Trop Med Hyg; 2019 Oct; 101(4):780-788. PubMed ID: 31407656
[TBL] [Abstract][Full Text] [Related]
14. Detection of Leishmania RNA virus in Leishmania parasites.
Zangger H; Ronet C; Desponds C; Kuhlmann FM; Robinson J; Hartley MA; Prevel F; Castiglioni P; Pratlong F; Bastien P; Müller N; Parmentier L; Saravia NG; Beverley SM; Fasel N
PLoS Negl Trop Dis; 2013; 7(1):e2006. PubMed ID: 23326619
[TBL] [Abstract][Full Text] [Related]
15. In situ study of cellular immune response in human cutaneous lesions caused by Leishmania (Viannia) panamensis in Panama.
Gonzalez K; Calzada JE; Tomokane TY; Pacheco CMS; Flores GVA; Castro Gomes CM; Pereira Corbett CE; Saldaña A; Laurenti MD
Parasite Immunol; 2021 Mar; 43(3):e12801. PubMed ID: 33068443
[TBL] [Abstract][Full Text] [Related]
16. Leishmania (Viannia) guyanensis induces low immunologic responsiveness in leishmaniasis patients from an endemic area of the Brazilian Amazon Highland.
Matta NE; Nogueira RS; Franco AM; de Souza E Souza I; Mattos MS; Oliveira-Neto MP; Coutinho SG; Leon LL; Da-Cruz AM
Am J Trop Med Hyg; 2009 Mar; 80(3):339-44. PubMed ID: 19270278
[TBL] [Abstract][Full Text] [Related]
17. Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.
Guerra JA; Prestes SR; Silveira H; Coelho LI; Gama P; Moura A; Amato V; Barbosa Md; Ferreira LC
PLoS Negl Trop Dis; 2011 Mar; 5(3):e980. PubMed ID: 21408116
[TBL] [Abstract][Full Text] [Related]
18. Influence of Leishmania RNA Virus 1 on Proinflammatory Biomarker Expression in a Human Macrophage Model of American Tegumentary Leishmaniasis.
Kariyawasam R; Grewal J; Lau R; Purssell A; Valencia BM; Llanos-Cuentas A; Boggild AK
J Infect Dis; 2017 Oct; 216(7):877-886. PubMed ID: 28968786
[TBL] [Abstract][Full Text] [Related]
19. Reproductive strategies and population structure in Leishmania: substantial amount of sex in Leishmania Viannia guyanensis.
Rougeron V; Bañuls AL; Carme B; Simon S; Couppié P; Nacher M; Hide M; De Meeûs T
Mol Ecol; 2011 Aug; 20(15):3116-27. PubMed ID: 21722225
[TBL] [Abstract][Full Text] [Related]
20. Detection of Leishmania RNA Virus 1 in Leishmania (Viannia) panamensis Isolates, Panama.
Gonzalez K; De León SS; Pineda V; Samudio F; Capitan-Barrios Z; Suarez JA; Weeden A; Ortiz B; Rios M; Moreno B; Gundacker ND; Pascale JM; López-Vergès S; Sosa N; Saldaña A; Ábrego LE
Emerg Infect Dis; 2023 Jun; 29(6):1250-1253. PubMed ID: 37209675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
